Home » Topics » BioWorld Science

BioWorld Science
RSS

Aqualung Therapeutics wins award to support development of therapies for ARDS

June 7, 2019

InflaRx reports topline results from phase IIb SHINE study of IFX-1 in hidradenitis suppurativa

June 6, 2019

Metabomed identifies acetyl-coenzyme A synthetase, cytoplasmic inhibitors

June 6, 2019

Hepagene Therapeutics patents MEK kinase 5 inhibitors

June 6, 2019

Senju Pharmaceutical synthesizes new PAC1 and/or VPAC1 and/or VPAC2 receptor ligands

June 6, 2019

New mGlu2 negative allosteric modulators synthesized at Sumitomo Dainippon Pharma

June 6, 2019

Novartis discovers HBsAg secretion inhibitors

June 6, 2019

Concert Pharmaceuticals presents phase I preliminary data for CTP-692

June 6, 2019

Vaccitech initiates phase IIb study of MVA-NP+M1 universal flu vaccine in Belgium

June 6, 2019

Phase III study of Ninlaro in systemic AL amyloidosis misses first of two primary endpoints

June 6, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...